Status:
UNKNOWN
Use of an Air Warming Mask for Exercise in Patients With COPD V1.0
Lead Sponsor:
University of Worcester
Conditions:
Chronic Obstructive Pulmonary Disease
Eligibility:
All Genders
40-80 years
Phase:
NA
Brief Summary
The World Health Organisation defines chronic obstructive pulmonary disease (COPD) as 'not one single disease but an umbrella term used to describe chronic lung diseases that cause limitations in lung...
Detailed Description
Purpose and design Previous studies have demonstrated the detrimental effect of inhaled cold air for COPD sufferers \[1\]. Recommendations for COPD sufferers suggest covering the mouth or mouth and ...
Eligibility Criteria
Inclusion
- Males or females diagnosed with COPD, GOLD stage 2 to stage 4
- Stable COPD
- ≥40 years old
- Ability to walk for 6 minutes without stopping
- Medical Research Council (MRC) scale of dyspnoea - grade 3 or above (grade 3 means a patient is limited to walking slower than contemporaries on the level because of breathlessness, or has to stop for breath when walking at own pace).
Exclusion
- Significant disease other than COPD
- Ischaemic heart disease
- Use of supplemental oxygen therapy
- Participants who are unable to walk
- Unstable or life-threatening cardiac arrhythmia
- History of myocardial infarction
- Cold, flu like illness, or other chest infection in the last 8 weeks
- Participants who are currently experiencing an exacerbation of their COPD
- Participants who have experienced an exacerbation in the previous 8 weeks
- Participants who have a known reaction to medical plastics
Key Trial Info
Start Date :
March 1 2012
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
July 1 2015
Estimated Enrollment :
24 Patients enrolled
Trial Details
Trial ID
NCT02266316
Start Date
March 1 2012
End Date
July 1 2015
Last Update
October 17 2014
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Worcester
Worcester, Worcestershire, United Kingdom, WR2 6AJ